Search
Procept Biorobotics Corp
PRCTAdd to Watchlist
21.765USD
-1.705-7.26%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.22BMarket Cap
LossP/E TTM
More Details of Procept Biorobotics Corp Company
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Procept Biorobotics Corp Info
Ticker SymbolPRCT
Company nameProcept Biorobotics Corp
IPO dateSep 15, 2021
CEOWood (Larry L)
Number of employees756
Security typeOrdinary Share
Fiscal year-endSep 15
Address150 Baytech Drive
CitySAN JOSE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code95134
Phone16502329832
Websitehttps://www.procept-biorobotics.com/
Ticker SymbolPRCT
IPO dateSep 15, 2021
CEOWood (Larry L)
Company Executives of Procept Biorobotics Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
4.10K
+80.83%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.20K
-9770.22%
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
Mr. Antal Desai
Mr. Antal Desai
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
FAQs
Who are the top five shareholders of Procept Biorobotics Corp?
The top five shareholders of Procept Biorobotics Corp are: Dr. Frederic H. (Fred) Moll, M.D.
How many institutions hold shares of Procept Biorobotics Corp (PRCT)?
As of 2026Q1, 597 institutions hold shares of Procept Biorobotics Corp, with a combined market value of approximately 65.01M, accounting for 114.22% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -1014187.00.
What is the biggest source of revenue for Procept Biorobotics Corp?
In 2026Q1, the Hand pieces and other consumables business generated the highest revenue for Procept Biorobotics Corp, amounting to 181.45M and accounting for 58.90% of total revenue.